News & Analysis on Clinical Trial Services & Contract Research And Development
Novartis has been keen to shout about data published this week in the Journal of the American Medical Association (JAMA) that backs up claims that it has developed the first vaccine to protect infants against the most common meningitis subgroups.
Diagnostics firm bioMérieux has announced plans to shift activities at its facility in the Netherlands to France, shutting down the Dutch site as it continues to haemorrhage cash.
Thousands of rodents lives will be saved each year after a specific animal test is being scrapped following a review by 18 pharmaceutical companies.
Outsourcing-Pharma.com compiles the news that has featured in the clinical contract community of late, involving Encorium Group, Holmes Biopharma and Novotech.
The world's generics titan, Teva, has reportedly earmarked over $1bn to fuel an ambitious plan to broaden its presence in India.
US firms Multispan and Promega have paired up to develop assay tools for G-protein coupled receptor (GPCR) screening, in the hope of speeding up drug discovery on these, the most popular protein targets in pharma.
Japan's number two pharma firm has elected to set up significant operations in India - the first Japanese pharma company planning to plant itself in the country on such a scale.